HCMPX
Price
$20.42
Change
-$1.12 (-5.20%)
Updated
Dec 18 closing price
RWIBX
Price
$62.66
Change
-$1.77 (-2.75%)
Updated
Dec 18 closing price
Ad is loading...

HCMPX vs RWIBX

Header iconHCMPX vs RWIBX Comparison
Open Charts HCMPX vs RWIBXBanner chart's image
HCM Dividend Sector Plus Investor
Price$20.42
Change-$1.12 (-5.20%)
VolumeN/A
CapitalizationN/A
American Funds Capital World Gr&Inc R2
Price$62.66
Change-$1.77 (-2.75%)
VolumeN/A
CapitalizationN/A
HCMPX vs RWIBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
HCMPX vs. RWIBX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HCMPX is a Hold and RWIBX is a Buy.

FUNDAMENTALS
Fundamentals
RWIBX has more cash in the bank: 121B vs. HCMPX (1.78B). RWIBX pays higher dividends than HCMPX: RWIBX (1.05) vs HCMPX (0.00). HCMPX was incepted earlier than RWIBX: HCMPX (10 years) vs RWIBX (23 years). HCMPX is a more actively managed with annual turnover of: 178.00 vs. RWIBX (27.00). RWIBX has a lower initial minimum investment than HCMPX: RWIBX (250) vs HCMPX (2500). HCMPX annual gain was more profitable for investors over the last year : 23.51 vs. RWIBX (11.34). HCMPX return over 5 years is better than : 78.98 vs. RWIBX (29.64).
HCMPXRWIBXHCMPX / RWIBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years23 years-
Gain YTD28.8289.781295%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.78B121B1%
Annual Yield % from dividends0.001.05-
Returns for 1 year23.5111.34207%
Returns for 3 years6.008.4171%
Returns for 5 years78.9829.64266%
Returns for 10 yearsN/A44.22-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LITM0.180.03
+17.46%
Snow Lake Resources Ltd
NUVB2.810.12
+4.46%
Nuvation Bio
ENTG109.362.65
+2.48%
Entegris
ARQ7.01-0.04
-0.57%
Arq
PTCT47.02-1.59
-3.27%
PTC Therapeutics